Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.
about
Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cellsTFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancerMethylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancerHypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer.Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinomaDiagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation.Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma.Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.TFPI2AS1, a novel lncRNA that inhibits cell proliferation and migration in lung cancer.Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.
P2860
Q33308310-3612F5D9-5AFD-43B9-8BB6-5127E23EA24CQ33742715-8958EBF6-BB08-41B7-8252-3A6100B383CBQ34623032-10982CA6-063C-442A-B0F0-EBFD0EA6B3A0Q34706624-0F3E58D5-B558-4B6E-8735-B7426490EF18Q35405533-B20963F1-B447-4D1D-8ACB-B055293C6710Q35688507-0128813C-660D-488B-871B-341698C245FFQ35858377-CBA2B6C5-A985-46CD-92EF-6DC5B9DBB566Q37043566-DB0D9AF2-CDB6-49DB-937D-16DADFD77B67Q37225785-38187981-44DF-4D69-93F8-DA8D25D89B78Q37294488-6BB08ED0-CE57-4BAC-93DC-74CFFE8FC435Q37536997-724B1AF9-281E-49FB-8462-1BF0567357E5Q38938718-3CE0FCEF-D9F6-45FE-9505-E5A79A1D8F2CQ40233356-9265E2F6-DD6B-4756-912B-1A2A50878EA7Q40277662-DE98F716-487C-4412-A4D3-24DCEE948447Q41447190-9EDBD3FF-BB13-43F3-A604-1E0C985D7123Q41779392-FB3878EC-C93C-45FF-BEC4-089C02DA9AA3Q42670733-002F8D08-C09A-49A9-A825-0C1CEA9844DBQ46123774-C0789289-B188-4050-8C32-0EB2E4660D00Q47766662-C8396A5F-F7FF-4F7A-9E79-4FC1AF18D948Q53262777-FC8FC89A-8967-45FE-9BE0-C28890595152
P2860
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression and methylation sta ...... in non-small-cell lung cancer.
@ast
Expression and methylation sta ...... in non-small-cell lung cancer.
@en
type
label
Expression and methylation sta ...... in non-small-cell lung cancer.
@ast
Expression and methylation sta ...... in non-small-cell lung cancer.
@en
prefLabel
Expression and methylation sta ...... in non-small-cell lung cancer.
@ast
Expression and methylation sta ...... in non-small-cell lung cancer.
@en
P2093
P2860
P50
P356
P1476
Expression and methylation sta ...... in non-small-cell lung cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602298
P407
P577
2005-02-01T00:00:00Z